Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 3,800 | -14,811 | 10,827 | 14,615 | 27,966 |
| Cost of Goods | 385 | -27,268 | 9,213 | 11,754 | 8,145 |
| Gross Profit | 3,415 | 12,457 | 1,614 | 2,861 | 19,821 |
| Operating Expenses | 33,028 | 15,918 | 44,194 | 41,094 | 39,872 |
| Operating Income | -29,228 | -3,725 | -42,368 | -37,481 | -19,907 |
| Interest Expense | 1,358 | 0 | 0 | 0 | 0 |
| Other Income | 2,270 | 4,003 | 2,297 | -4,129 | 4,561 |
| Pre-tax Income | -28,316 | 278 | -40,071 | -41,610 | -15,346 |
| Net Income Continuous | -28,316 | 278 | -40,071 | -41,610 | -15,346 |
| Net Income Discontinuous | -6,441 | N/A | N/A | N/A | N/A |
| Minority Interests | -2,846 | -3,083 | -2,658 | -1,691 | -3,478 |
| Net Income | $-31,911 | $-24,997 | $-37,413 | $-39,919 | $-11,868 |
| EPS Basic Total Ops | -0.70 | -0.57 | -0.82 | -0.88 | -0.28 |
| EPS Basic Continuous Ops | -0.62 | 0.00 | -0.88 | -0.92 | -0.36 |
| EPS Basic Discontinuous Ops | -0.14 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.70 | -0.57 | -0.82 | -0.88 | -0.28 |
| EPS Diluted Continuous Ops | -0.62 | 0.00 | -0.88 | -0.92 | -0.36 |
| EPS Diluted Discontinuous Ops | -0.14 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-24,327 | $-1,111 | $-38,002 | $-34,072 | $-16,140 |